menu
    • menu

    Company profile for ScieGen Pharmaceuticals

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ScieGen Pharmaceuticals, Inc is a fast growing generic pharmaceutical company located in Hauppauge, NY. Our core business is in the areas of Development, Manufacturing, Marketing and Distribution of high quality and cost effective generic pharmaceutical products. ScieGen has robust product development pipeline and filed a couple of ANDA’s. We aim to provide healthcare at economical prices to make this a healthier world to li...
    ScieGen Pharmaceuticals, Inc is a fast growing generic pharmaceutical company located in Hauppauge, NY. Our core business is in the areas of Development, Manufacturing, Marketing and Distribution of high quality and cost effective generic pharmaceutical products. ScieGen has robust product development pipeline and filed a couple of ANDA’s. We aim to provide healthcare at economical prices to make this a healthier world to live in.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ScieGen PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Davids Driv, Hauppauge, NY 11788
    Telephone
    Telephone
    1-855-724-3436
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sciegenpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ScieGen’s Generics Dapagliflozin Receive Tentative Approval in US
    ScieGen’s Generics Dapagliflozin Receive Tentative Approval in US

    08 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219408

    FDA
    08 Jan 2026
    Share Share
    Sciegen’s Generics Ticagrelor Receives Approval in US
    Sciegen’s Generics Ticagrelor Receives Approval in US

    28 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218962

    FDA
    28 Oct 2025
    Share Share
    Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
    Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US

    10 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211663

    FDA
    10 Dec 2024
    Share Share
    ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
    ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.

    06 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216327

    FDA
    06 Apr 2023
    Share Share
    Enforcement Report - Week of March 8, 2023
    Enforcement Report - Week of March 8, 2023

    08 Mar 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf

    FDA
    08 Mar 2023
    Share Share
    ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
    ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.

    23 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216521

    FDA
    23 Sep 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search